[Drug-induced lung diseases].
Drug-induced lung diseases may present themselves as bronchial reactions (e.g. bronchial asthma), diseases of the parenchyma (e.g. pulmonary infiltrates with eosinophilia, diffuse fibrosing alveolitis), of the pulmonary vasculature (vasculitis) and of the pleura (e.g. pleurisy or pleural fibrosis). Pathogenetically the two most pertinent types of reaction are hypersensitivity or toxic reactions, and less often biologic reactions such as opportunistic infections after cytotoxic and immunosuppressive therapy. Many drug-induced respiratory diseases are reversible upon withdrawal of the offending agent; others may be irreversible or even progress.
D001241:Aspirin / Q000009:adverse effects; D001249:Asthma / Q000139:chemically induced; D001991:Bronchitis / Q000139:chemically induced; D002066:Busulfan / Q000009:adverse effects; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity; D004347:Drug Interactions; D004361:Drug Tolerance; D003932:Heroin / Q000009:adverse effects; D006801:Humans; D007454:Iodides / Q000009:adverse effects; D008171:Lung Diseases / Q000139:chemically induced*; D008784:Methysergide / Q000009:adverse effects; D010909:Pituitary Hormones, Posterior / Q000009:adverse effects; D010995:Pleural Diseases / Q000139:chemically induced; D010488:Polyarteritis Nodosa / Q000139:chemically induced; D011654:Pulmonary Edema / Q000139:chemically induced; D011655:Pulmonary Embolism / Q000139:chemically induced; D011657:Pulmonary Eosinophilia / Q000139:chemically induced; D014357:Trypsin / Q000009:adverse effects
D003278:Contraceptives, Oral, Hormonal; D007454:Iodides; D010909:Pituitary Hormones, Posterior; D003932:Heroin; D014357:Trypsin; D002066:Busulfan; D001241:Aspirin; D008784:Methysergide
Medikamentös bedingte Pneumopathien.